title: Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample.
abstract: We studied the association between allergy defined as eosinophilia (>/= 275 cells/mm(3)) and/or positive skin tests (sum score >/= 3) and mortality from chronic obstructive pulmonary disease (COPD) after adjustment for major risk factors. In addition, we investigated this association in subgroups of respiratory symptoms and lung function. We used data from 7,556 participants of the respiratory surveys in 1964 -1972 in the general populations of Vlagtwedde, Vlaardingen, and Meppel (The Netherlands; mean age +/- SD: 39.3 yr +/- 14 in the 1960s). In 1995, the vital status was available (5,135 alive, 106 lost to follow-up, 121 primary deaths from COPD, and 2,194 other primary causes of which 137 had a secondary death cause from COPD. Positive skin tests were not associated with increased COPD mortality. The association between eosinophilia and COPD mortality was restricted to those who had reported asthma attacks and was present for both COPD as a primary cause (relative risk [RR] = 4.80; 95% confidence interval [CI] 1.9 to 11.9) and combined primary and secondary causes of death (RR = 3. 90; 95% CI 2.05 to 7.40). We conclude that eosinophilia with asthma attacks is a risk factor for COPD mortality in addition to known risk factors also found in our study such as male gender, older age, current smoking, low lung function, underweight, and dyspnea.
authors.affiliation: Departments of Epidemiology and Statistics and Pulmonology, University of Groningen, The Netherlands.
authors.forename: J J
authors.initials: JJ
authors.lastname: Hospers
authors.forename: J P
authors.initials: JP
authors.lastname: Schouten
authors.forename: S T
authors.initials: ST
authors.lastname: Weiss
authors.forename: B
authors.initials: B
authors.lastname: Rijcken
authors.forename: D S
authors.initials: DS
authors.lastname: Postma
mesh_terms: D000293:Adolescent; D000328:Adult; D000485:Allergens; D001249:Asthma / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D015992:Body Mass Index; D016001:Confidence Intervals; D004802:Eosinophilia / Q000150:complications*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D012307:Risk Factors; D012882:Skin Tests; D012907:Smoking; D013147:Spirometry
chemical_list: D000485:Allergens